By
The growing role of 3D printing in prosthetics is reshaping the orthotics and prosthetics (O&P) industry, and the 2025 acquisition of Point Designs by Hanger, Inc. highlights how research-driven innovation can move from the laboratory to large-scale clinical delivery. The deal reflects a broader shift in the industry, where additive manufacturing is no longer experimental, but increasingly part of mainstream patient care.
Point Designs began as a research-driven startup connected to the University of Colorado, where engineers and clinicians worked on improving upper-limb prosthetic technology using advanced mechanical design and additive manufacturing. The company focused on developing durable, functional prosthetic fingers for people with partial hand loss, using high-strength 3D-printed components to achieve both performance and customization.
Unlike traditional prosthetic components that rely heavily on manual fabrication, the use of 3D printing allowed Point Designs to produce complex mechanical structures with high precision and repeatability. This approach enabled lighter devices, faster production, and easier customization for individual patients, which are key advantages in upper-limb prosthetics where fit and function are critical.
The company’s growth attracted the attention of Hanger, one of the world’s largest orthotics and prosthetics care providers, which operates hundreds of clinics and distributes O&P products across the United States. In July 2025, Hanger announced an agreement to acquire Point Designs, aiming to integrate its advanced prosthetic finger technology into a wider clinical network and expand access to innovative upper-limb solutions.
The acquisition illustrates a larger trend in the O&P sector. As reimbursement systems evolve and digital workflows become more common, companies that combine engineering, clinical knowledge, and scalable manufacturing are becoming increasingly valuable. Additive manufacturing makes it possible to produce complex devices efficiently, but large providers like Hanger are needed to deliver those devices to patients through established clinical pathways.
This transition from university research to commercial adoption also shows how collaboration between academia, startups, and clinical providers is accelerating innovation in rehabilitation technology. What once existed only in research laboratories can now reach patients worldwide through integrated care networks.
For the O&P profession, the story of Point Designs demonstrates that the future of prosthetics will likely depend on the combination of digital design, additive manufacturing, and strong clinical infrastructure. As 3D printing continues to mature, partnerships between innovators and large service providers may become one of the main ways new technology moves from concept to real-world patient care.
